Contact this trialFirst, we need to learn more about you.
V940 + Pembrolizumab for Kidney Cancer
Recruiting0 awardsPhase 2
Philadelphia, Pennsylvania
This trial aims to see if adding V940 to pembrolizumab is better than adding a placebo to pembrolizumab in terms of how long patients remain free of disease. The main
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service